Premalignant gastric lesions in patients included in National colorectal cancer screening

	Age range	N	Mean	Std. Deviation	Std. Error
G 17 basal (pmol/L)	50–59 years	105	7.1860	8.6474	0.8439
	60–69 years	99	17.8350	99.0131	9.9512
	70+ years	32	8.9800	10.7870	1.9069
	Total	236	11.8970	64.5188	4.1998
PGI (µg/L)	50–59 years	134	95.9870	42.1806	3.6438
	60–69 years	120	97.9820	42.5086	3.8805
	70+ years	34	87.4010	53.5304	9.1804
	Total	288	95.8050	43.7446	2.5777
PGII (µg/L)	50–59 years	134	11.7030	10.3706	0.8959
	60–69 years	120	12.1780	9.4390	0.8617
	70+ years	34	12.9740	9.4896	1.6275
	Total	288	12.0480	9.8640	0–0581
PGI/PGII ratio	50–59 years	134	10.0840	4.4246	0.3822
	60–69 years	120	9.6950	4.6364	0.4232
	70+ years	34	7.6100	3.7772	0.6478
	Total	288	9.6300	4.4953	0.2849
Helicobacter pylori Ab titre (EIU)	50–59 years	134	72.9270	46.5802	4.0239
	60–69 years	120	80.8910	42.3679	3.8676
	70+ years	34	91.2500	51.0485	8.7547
	Total	288	78.4090	45.6677	2.2610

[i] G 17 = Gastrin 17; PGI = Prostaglandin I; PGII = Prostaglandin II

Table 3

Gastropanel data for men and women

	N	Mean	Std. Deviaton	Std. error
G 17 basal (pmol/L)	W 109	16.4890	94.3688	9.0389
	M 127	7.9550	9.8272	0.8720
	T 236	11.8670	64.5188	4.1998
PGI (µg/L)	W 134	95.4210	44.0496	3.8053
	M 154	96.1380	43.6186	3.5149
	T 288	95.8050	43.7446	2.5777
PGII (µg/L)	W 134	13.1840	12.5659	1.0855
	M 154	11.0600	6.5683	0.5293
	T 288	12.0480	9.8640	0.5812
PGI/PGII ratio	W 134	9.4370	4.5881	0.3963
	M 154	9.7980	4.4210	0.3563
	T 288	9.6300	4.4953	0.2649
Helicobacter pylori Ab titre (EIU)	W 134	75.8700	47.1760	4.0754
	M 154	80.6170	44.3496	3.5738
	T 288	78.4090	45.6677	2.6910

[i] G 17 = Gastrin 17; PGI = Prostaglandin I; PGII = Prostaglandin II

Table 4

Histologic phenotypes of gastric mucosa according to Gastropanel results

	Frequency	Percent	Valid percent	Cumulative percent
Normal panel	73.00	25.30	25.30	25.30
HP gastritis	199.00	69.10	69.10	94.40
AGA	1.00	0.30	0.30	94.80
AGC	15.00	5.20	5.20	100.00
Total	288	100	100

[i] AGA = Atrophic gastritis of antrum; AGC = Atrophic gastritis of corpus

Prostaglandin I (PGI) / Prostaglandin II (PGII) ratio according to Operative Link on Gastric Intestinal Metaplasia Assessment (OLGIM) stage.

Table 5

Age Group H. pylori positive vs. negative

		Hp positive vs negative
	Age Group			Total
		HP+	Hp-
50-59	Count	94	40	134
50-59	% within Age Group	70.1%	29.9%	100.0%
60-69	Count	96	24	120
60-69	% within Age Group	80,0%	20.0%	100.0%
70+	Count	29	5	34
70+	% within Age Group	85.3%	14.7%	100.0%
Total	Count	219	69	288
Total	% within Age Group	76.0%	24.0%	100.0%

References

Authors

Metrics

Articles in this issue

DOI: https://doi.org/10.1515/raon-2017-0054 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099

Journal RSS Feed

Language: English

Page range: 7 - 13

Submitted on: Sep 11, 2017

Accepted on: Oct 10, 2017

Published on: Dec 7, 2017

Published by: Association of Radiology and Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

gastropanel,

Helicobacer pylori,

atrophy,

intestinal metaplasia,

Related subjects:

© 2017 Bojan Tepes, Maja Seruga, Miroslav Vujasinovic, Dejan Urlep, Liljana Ljepovic, Jurecic Nataša Brglez, Alenka Forte, Ljubec Anita Kek, Miha Skvarc, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 52 (2018): Issue 1 (March 2018)

Premalignant gastric lesions in patients included in National colorectal cancer screening

Figures & Tables

Table 1

Table 2

Table 3

Table 4

Figure 1

Table 5

Paradigm

My account